Skip to content
Shuttingdown

Lunai Bioworks Inc.

Pharmaceutical Preparations · SUITE 906 LOS ANGELES · CA

Distress signal

Moderate confidence (50%)

Updated Oct 18, 2026, 12:04 AM

What is happening

Derived by rule set status-rules-2026.09.7

An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

Latest material event: Lunai Bioworks Inc. received a delisting notice from its exchange (Apr 27, 2026)

Timeline

Every material event, newest first. History is never overwritten.

  1. Lunai Bioworks Inc. received a delisting notice from its exchange

    Apr 27, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, on February 6, 2026, the Company received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that the Staff had determined to delist the Company s common stock from The Nasdaq Capital Market. The Company timely requested a hearing before the Nasdaq Hearings Panel (the Panel ), which stayed the delisting action pending the Panel s decision. On April 20, 2026, the Company received notice from the Panel…”

  2. Lunai Bioworks Inc. received a delisting notice from its exchange

    Feb 17, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On February 6, 2026, Lunai Bioworks Inc. (the Company ) received a letter from the Listing Qualifications Staff (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that the Staff had determined to delist the Company s securities from Nasdaq. As previously disclosed, the Company timely requested a hearing before the Nasdaq Hearings Panel (the Panel ) to appeal the Staff s determination. On February 17, 2026, the Company received written notice from Nasdaq that…”

  3. Lunai Bioworks Inc. received a delisting notice from its exchange

    Feb 6, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On February 6, 2026, Lunai Bioworks, Inc. (the Company ) received a written notice (the Notice ) from the Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that Nasdaq staff has determined to delist the Company s securities from The Nasdaq Capital Market. The Notice states that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share, as the bid price of the Company s sec…”

Company information

Founded
—
Employees (estimate)
—
Industry
Pharmaceutical Preparations
Subindustry
—
Listing
SEC lists the ticker LNAI on Nasdaq.
SEC CIK
0001527728
Website
—
LinkedIn
—
Headquarters
SUITE 906 LOS ANGELES, CA
Also known as
DanDrit Biotech USA, Inc., Enochian Biosciences Inc, Putnam Hills Corp., RENOVARO INC., RENOVARO BIOSCIENCES INC.
Legal entities
Lunai Bioworks Inc.

Sources

Every material source used to build this profile.

  • SEC Company Submissions (TIER 1 · UNVERIFIED)

    Lunai Bioworks Inc. — Pharmaceutical Preparations (SIC 2834) — SUITE 906 LOS ANGELES, CA
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, on February 6, 2026, the Company received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that the Staff had determined to delist the Company s common stock from The Nasdaq Capital Market. The Company timely requested a hearing before the Nasdaq Hearings Panel (the Panel ), which stayed the delisting action pending the Panel s decision. On April 20, 2026, the Company received notice from the Panel…
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On February 6, 2026, Lunai Bioworks Inc. (the Company ) received a letter from the Listing Qualifications Staff (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that the Staff had determined to delist the Company s securities from Nasdaq. As previously disclosed, the Company timely requested a hearing before the Nasdaq Hearings Panel (the Panel ) to appeal the Staff s determination. On February 17, 2026, the Company received written notice from Nasdaq that…
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On February 6, 2026, Lunai Bioworks, Inc. (the Company ) received a written notice (the Notice ) from the Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that Nasdaq staff has determined to delist the Company s securities from The Nasdaq Capital Market. The Notice states that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share, as the bid price of the Company s sec…
    View source record

Status history

Every derived status, with the rule that produced it.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:31 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:15 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:32 PM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:46 PM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:09 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.